Drugs / Egg-based Quadrivalent Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05606965 Comparator | Nov 2022 → Nov 2025 | influenza | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Egg-based Quadrivalent Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05606965 ↗ |
| Modality | Vaccine | “egg-based quadrivalent influenza vaccine” NCT05606965 ↗ |
| Route | Intramuscular | “by IM injection” NCT05606965 ↗ |